BRCA2 and breast carcinoma: In contrast, male breast cancer patients harboring BRCA2 mutations (n=4) had an older mean age of diagnosis than non-carriers (n=22) (66.5 years (range 54-76) and 52.5 years (range 27-69) years, respectively, p=0.039, Wilcoxon rank-sum test).